Family Medicine · Oklahoma City, OK
NPI
1407903644
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
9
Medicare group memberships
Hospitals
5
Hospital affiliations
5721 NW 132nd St
Oklahoma City, OK, 73142
Phone (405) 557-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$330K
4,669 services
Medicare patients, 2024
1,041
Average age 78
Drug cost, 2024
$4.5M
59,125 prescriptions
Company payments, 2025
$596
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Corey D Finch Sr. was code 99309 (snf e&m), 1,490 times for 445 patients. In total Corey D Finch Sr. billed 4,669 services in 34 codes, and Medicare paid $330K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 1,490 | 445 | $78.17 | $116K |
| 99309 SNF E&M | Office | 1,239 | 351 | $75.63 | $94K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 297 | 93 | $46.26 | $14K |
| 99497 Care Management/Coordination | Facility | 235 | 216 | $56.07 | $13K |
| 99305 SNF E&M | Facility | 213 | 196 | $98.61 | $21K |
| 99308 SNF E&M | Facility | 203 | 129 | $54.29 | $11K |
| 99497 Care Management/Coordination | Office | 196 | 173 | $62.18 | $12K |
| 99305 SNF E&M | Office | 144 | 125 | $96.04 | $14K |
| 99490 Chronic, Principal, and Transitional Care Management | Facility | 108 | 56 | $37.35 | $4,034 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 90 | 59 | $35.38 | $3,184 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 69 | 44 | $26.58 | $1,834 |
| 99308 SNF E&M | Office | 52 | 44 | $49.96 | $2,598 |
| 99349 Home E&M - New and Established | Office | 47 | 30 | $90.72 | $4,264 |
| 99439 Chronic, Principal, and Transitional Care Management | Facility | 42 | 40 | $26.08 | $1,095 |
| 96138 Behavioral Health Services | Office | 41 | 41 | $20.12 | $825 |
By year: 2022 $1.2M for 7,046 services; 2023 $390K for 5,716 services; 2024 $330K for 4,669 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 14 | $8.40 | $118 |
Medicare prescription drug claims, 2024
In 2024, the drug Corey D Finch Sr. prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,682 prescriptions and refills. In total Corey D Finch Sr. wrote 59,125 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,682 | 2,735 | 490 | $42K |
| Eliquis Apixaban | 2,192 | 2,216 | 273 | $698K |
| Levothyroxine Sodium Generic | 2,016 | 2,109 | 334 | $27K |
| Furosemide Generic | 1,915 | 1,963 | 357 | $13K |
| Potassium Chloride Generic | 1,813 | 1,868 | 344 | $41K |
| Amlodipine Besylate Generic | 1,693 | 1,766 | 321 | $19K |
| Pantoprazole Sodium Generic | 1,583 | 1,601 | 303 | $27K |
| Gabapentin Generic | 1,572 | 1,599 | 331 | $31K |
| Omeprazole Generic | 1,399 | 1,429 | 242 | $20K |
| Lisinopril Generic | 1,378 | 1,426 | 245 | $14K |
| Sertraline Hcl Generic | 948 | 992 | 185 | $12K |
| Donepezil Hcl Generic | 940 | 960 | 160 | $19K |
| Tamsulosin Hcl Generic | 923 | 939 | 191 | $16K |
| Memantine Hcl Generic | 911 | 943 | 147 | $38K |
| Carvedilol Generic | 905 | 921 | 168 | $11K |
Brand drugs: 8,843 claims; generic drugs: 49,671 claims; opioid claims: 1,529.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Corey D Finch Sr. $596 ($596 in general payments such as food, travel and fees) from 12 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $196.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $196 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $136 |
| Acarix USA Inc. | 1 | $43.99 |
| Pfizer Inc. PFE | 2 | $39.13 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $34.32 |
| Corcept Therapeutics CORT | 1 | $30.99 |
| SK Life Science, Inc. | 1 | $23.64 |
| UCB, Inc. UCB.BR | 1 | $21.81 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $18.9 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $18.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.